GenMark Diagnostics (GNMK) reported a fourth quarter loss of $0.15 per share after the close Tuesday, compared to the loss of $0.27 per share last year. The consensus estimate was for a loss of $0.21.
GenMark Diagnostics gapped up Wednesday and climbed during the first hour of trade, before settling into a range. Shares finished with a gain of 1.11 at $12.16 on above average volume. The stock rose above a 2-month range and set a new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.